The Experience of Greece as a Model to Contain COVID-19 Infection Spread

In Vivo. 2021 Mar-Apr;35(2):1285-1294. doi: 10.21873/invivo.12380.

Abstract

The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in late 2019 and has caused a pandemic known as corona virus disease 2019 (COVID-19), responsible for the death of more than 2 million people worldwide. The outbreak of COVID-19 has posed an unprecedented threat on human lives and public safety. The aim of this review is to describe key aspects of the bio-pathology of the novel disease, and discuss aspects of its spread, as well as targeted protective strategies that can help shape the outcome of the present and future health crises. Greece is used as a model to inhibit SARS-COV-2 spread, since it is one of the countries with the lowest fatality rates among nations of the European Union (E.U.), following two consecutive waves of COVID-19 pandemic. Furthermore, niche research technological approaches and scientific recommendations that emerged during the COVID-19 era are discussed.

Keywords: COVID-19; Greece; SARS-CoV-2; epidemiology; laboratory medicine; pandemic; policymaking; population screening; review; targeted protective measures.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • Child
  • Child, Preschool
  • Communicable Disease Control / methods*
  • Communicable Diseases, Emerging / prevention & control*
  • Female
  • Geography
  • Greece / epidemiology
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Models, Theoretical
  • Pandemics
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification*
  • SARS-CoV-2 / physiology
  • Young Adult